Brief: Hao Tian Development Says On 13 July, Unit & Promethera Biosciences Entered JV Deal For Formation Of JV Co
July 14 (Reuters) - Hao Tian Development Group Ltd
0474.HK :
* HAO TIAN DEVELOPMENT- ON 13 JULY, UNIT & PROMETHERA
BIOSCIENCES
ENTERED JV DEAL FOR FORMATION OF JV CO
* HAO TIAN DEVELOPMENT- JV SHALL BE OWNED AS TO 60% BY ACESO
LIFE
SCIENCE AND 40% BY PROMETHERA BIOSCIENCES
* HAO TIAN DEVELOPMENT- JV TO DEVELOP BIOLOGICAL THERAPIES
FOR
TREATMENT OF LIVER DISEASES, AUTOIMMUNE DISEASES & TYPES OF
CANCER
* HAO TIAN DEVELOPMENT- CO TO SUBSCRIBE FOR CONVERTIBLE
BONDS UP
TO EURO 10 MILLION
Further company coverage: 0474.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceso Life Science
See all newsBrief: Aceso Life Science Disposes 18.3 Million Future Data Shares From 4 To 8 June
Brief: Aceso Life Science To Subscribe For Imagi Fin Group Shares For HK$167.32 Million
Brief: Aceso Life Science Expected To Record Profit For HY
Brief: Aceso Life Science Says Repaid All Outstanding Indebtedness In Full
Brief: Aceso Life Science Says New Facility Loan Of GBP87.3 Million For 3 Years